Media articles

12th February
Financial Times

Nasa technology to help increase stem cell output

Two iconic fields of science - space and stem cells - will come together today with the launch of technology to grow large numbers of stem cells, developed by Nasa.

Read More

WELCOME TO REGENETECH®

Regenetech® develops and offers intellectual property licenses in the area of Adult Stem Cell Expansion and therapeutic applications of adult stem cells.

Regenetech® uses a technology discovered by NASA in space experiments for growing three-dimensional (3D) stem cells in a weightless environment.

Regenetech’s research results indicate that adult stem cells can be harvested from a filtered extraction of the patient's own blood and grown to larger, therapeutic quantities eliminating the most critical problem in conventional adult stem cell therapies: availability of adult stem cells rapidly, safely, and at reasonable cost. This minimally invasive procedure reintroduces the patient’s own stem cells to provide red and white blood cells, platelets, and connective tissues.

Regenetech® has the exclusive rights to thirteen (13) patents originally issued to NASA. The Company has added to the original technology licensed from NASA through its own technology creation program and has to date filed applications for 73 patents of its own with additional patent applications targeted.